News

Gilead’s three-arm Phase IIa trial evaluated the safety and efficacy of GS 9190, an oral polymerase inhibitor, in combination with GS 9256, an oral protease inhibitor, when used

Study 204 was a randomised, double-blind, placebo-controlled, two arm study of a single oral dose of 600 mg of NXN-188 for the treatment of moderate to severe acute

Avanir Pharma president and CEO Keith Katkin said that the FDA approval of Nuedexta marks an important milestone for people living with PBA. "The approval of Nuedexta also

Idenix Pharma has posted a net loss of $12.93m for the third quarter 2010, or $0.18 per diluted share, compared to $11.67m, or $0.18 per diluted share, for

Major players profiled in the report titled ‘Specialty Enzymes: A Global Strategic Business Report’ include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Codexis, Danisco, Genencor International,

Revolade is an oral treatment that stimulates the production of blood platelets, which are essential to normal clotting. GSK claimed that the anti-allergic drug, Xyzal, has been approved

Metoprolol Tartrate injection, USP is the generic equivalent of Lopressor, which is marketed by Novartis International, and is used in the treatment of acute myocardial infarction (AMI). APP

Nexium is indicated for the treatment of gastroesophageal reflux disease. As per the terms of the agreement, AstraZeneca and Daiichi Sankyo will co-promote the product after it is

Taro Pharma has posted a net income of $18.86m for the third quarter 2010, or $0.46 per diluted share, compared to $9.73m, or $0.24 per diluted share, for